ArticleThe Journal of dermatology2025

Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.

Hideshi Torii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.